ERBB2 and neoplasm: To conclude, in addition to the well-described pro-proliferative and pro-survival effects of HER2 dysregulation, it seems that HER2 alterations could also be involved in the promotion of hypoxia/angiogenesis, EMT and tumor immune escape based on findings made in various cancer models.